Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
90.00    -7.80 (-7.98%)
Bid:
89.20
Ask:
90.90
Spread: 1.70 (1.906%)
Market Cap: £147.55m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Trading Update

2 Jul 2015 07:00

RNS Number : 9208R
Synthomer PLC
02 July 2015
 

2nd July 2015

Synthomer plc

Trading Update

Synthomer plc ('Synthomer' or 'the Group') today issues a Trading Update ahead of its Interim Results on Tuesday 11 August 2015.

Overall, the Board's expectations for the full year remain unchanged.

Europe and North America

In our Q1 trading update, we reported that volumes were slightly behind the same period in 2014. We continued to see a similar trend in Q2, with volumes lower than the prior period primarily due to weaker demand in our Paper and Carpets businesses. As expected, the small margin benefit we experienced in Q1 from declining raw material prices did not continue in Q2, as modest raw material price inflation returned. Overall, operating profit in our Europe and North America segment is marginally behind the prior period in local currency, further behind on a reported basis (H1 2014: £47.8m) due to the weak Euro and consequently slightly behind current market expectations.

Asia and Rest of World

Our Asia and Rest of World segment has continued to experience both improved unit margins and strong demand similar to that seen in the first quarter, particularly in our Asian nitrile business. We have seen good volume growth and substantial margin growth, relative to the weaker performance in the first half of 2014. As a result, operating profit in our Asia and Rest of World segment for the first half of 2015 is materially ahead of the prior period (H1 2014: £7.3m) and current market expectations.

Financial Position

The Group continues to generate strong cash flows from all its operations and this, together with the benefit of the translation of the Euro denominated debt, will result in a further significant reduction in net debt at the end of the first six months. 

The Final 2014 Ordinary Dividend of 4.8p per share and the Special Dividend of 7.8p per share will be paid on 3 July 2015 resulting in a total cash payment to shareholders of approximately £43m.

Outlook

Looking forward to the second half, the economic and currency challenges in Europe are expected to have a continued impact on performance. This will be offset by Asia and Rest of World where, despite some softening in market conditions at the end of the first half, we remain confident of a continued strong performance. Overall, the Board's expectations for the full year remain unchanged.

 

Enquiries:

 

Calum MacLean, Chief Executive Officer

Tel: 01279 436 211

Stephen Bennett, Chief Financial Officer

Tel: 01279 775 250

Charles Armitstead, Pendomer

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGNVMVGKZM
Date   Source Headline
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM
3rd May 20181:38 pmRNSHolding(s) in Company
2nd May 20184:29 pmRNSDirector/PDMR Shareholding
26th Apr 20182:23 pmRNSResult of AGM
26th Apr 20187:00 amRNSQ1 Trading update
9th Apr 20184:54 pmRNSDirector Declaration
27th Mar 20181:03 pmRNSDirector/PDMR Shareholding
27th Mar 20181:01 pmRNSDirector/PDMR Shareholding
26th Mar 20184:55 pmRNSAnnual Financial Report
8th Mar 20184:39 pmRNSDirector/PDMR Shareholding
8th Mar 20184:37 pmRNSDirector/PDMR Shareholding
5th Mar 20182:43 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSResults for the year ended 31 December 2017
12th Feb 201810:27 amRNSDirector Declaration
1st Feb 20187:00 amRNSCompletion of the acquisition of BASF Pischelsdorf
2nd Jan 20187:00 amRNSDisposal of Synthomer Leuna Gmbh facility
13th Dec 20172:55 pmRNSDirector Declaration
4th Dec 20175:31 pmRNSHolding(s) in Company
27th Nov 20179:29 amRNSHolding(s) in Company
10th Nov 20179:40 amRNSDirectorate Change
9th Nov 201710:03 amRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSQ3 Trading update
9th Oct 20179:23 amRNSDirector Declaration
28th Sep 20177:00 amRNSAcquisition of BASF Pischelsdorf
18th Sep 20172:00 pmRNSHolding(s) in Company
17th Aug 201712:54 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSInterim Results for the 6 months ended 30 Jun 2017
1st Aug 20173:57 pmRNSHolding(s) in Company
10th Jul 201710:33 amRNSDirector/PDMR Shareholding
9th Jun 20173:14 pmRNSDirector/PDMR Shareholding
8th May 201712:40 pmRNSDirector/PDMR Shareholding
8th May 201712:24 pmRNSDirector/PDMR Shareholding
27th Apr 20174:05 pmRNSDirector Declaration
27th Apr 20172:53 pmRNSResult of AGM
27th Apr 20177:00 amRNSQ1 Trading update
27th Mar 20179:54 amRNSAnnual Financial Report
6th Mar 20177:02 amRNSAcquisition of Perstorp Belgium
6th Mar 20177:00 amRNSFinal Results
23rd Feb 20174:31 pmRNSAmendment TR-1 notification
8th Feb 20174:13 pmRNSHolding(s) in Company
6th Feb 201711:48 amRNSHolding(s) in Company
20th Jan 20177:00 amRNSQ4 and FY trading update
13th Dec 201610:57 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSCapital Markets Day
28th Nov 20169:51 amRNSHolding(s) in Company
18th Nov 20164:56 pmRNSHolding(s) in Company
16th Nov 201610:15 amRNSHolding(s) in Company
10th Nov 20162:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.